Luka Raguž

Luka Raguž

Auto-generated profile, based on publicly available information

Luka Raguž

Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
MCMathieu F. Chellat
Mathieu F. Chellat
LRLuka Raguž
Luka Raguž
Rainer RiedlRainer Riedl
Rainer Riedl
Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human‐pathogenic bacteria that are resistant to one or multiple antibiotics. More and more infections caused by resistant microorganisms fail to respond to conventional treatment, and in some cases, even last‐resort antibiotics have lost their power. In addition, industry pipelines for the development of novel antibiotics have run dry over the past decades. A recent world health day by the World Health Organization titled “Combat drug resistance: no action today means no cure tomorrow” triggered an increase in research activity, and several promising strategies have been developed to restore treatment options against infections by resistant bacterial pathogens.

22 March 2016 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
MCMathieu F. Chellat
Mathieu F. Chellat
LRLuka Raguž
Luka Raguž
Rainer RiedlRainer Riedl
Rainer Riedl
Neue Strategien zur Bekämpfung von Antibiotikaresistenzen zu finden, ist eine der größten globalen Herausforderungen für die Gesundheitssysteme. In den letzten Jahrzehnten gab es eine drastische Zunahme an humanpathogenen Bakterien, die resistent gegen Antibiotika sind. Immer mehr Infektionen, die durch resistente Mikroorganismen verursacht werden, lassen sich nicht mehr mit konventionellen Behandlungen kurieren, und selbst Reserveantibiotika verlieren ihre Wirkung. Zusätzlich sind die Entwicklungsströme an neuen Antibiotika aus der pharmazeutischen Industrie in den letzten Jahrzehnten versiegt. Die Weltgesundheitsorganisation hat mit ihrem Aufruf “Combat drug resistance: no action today means no cure tomorrow” eine Zunahme der Forschungsaktivitäten auf diesem Gebiet stimuliert, und mehrere neue, vielversprechende Strategien zur Wiederherstellung antibiotischer Behandlungsoptionen konnten seitdem entwickelt werden.

14 June 2018 in ACS Chemical Biology
Verified
Journal Article
Closed access
MRMaja Rischer
Maja Rischer
LRLuka Raguž
Luka Raguž
HGHuijuan Guo
Huijuan Guo
FKFrancois Keiff
Francois Keiff
GDGabriele Diekert
Gabriele Diekert
Christine BeemelmannsChristine Beemelmanns
Christine Beemelmanns

4 October 2018 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
HGHuijuan Guo
Huijuan Guo
ASAlexander Schmidt
Alexander Schmidt
PSPhilipp Stephan
Philipp Stephan
LRLuka Raguž
Luka Raguž
DBDaniel Daniel Braga
Daniel Daniel Braga
Christine BeemelmannsChristine Beemelmanns
Christine Beemelmanns

13 September 2017 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
DLD. Leichnitz
D. Leichnitz
LRL. Raguž
L. Raguž
Christine BeemelmannsChristine Beemelmanns
Christine Beemelmanns
Chemical communication is essential for all domains of life.

12 November 2024 in Chemical Science
Verified
Journal Article
Open access
PDF file
LBLukas Bissegger
Lukas Bissegger
TCTheodora Alexandra Alexandra Constantin
Theodora Alexandra Alexandra Constantin
EKErhan Keles
Erhan Keles
LRLuka Raguž
Luka Raguž
IBIsobel Barlow-Busch
Isobel Barlow-Busch
MWMatthias WYMANN
Matthias WYMANN
Optimised covalent PI3Kα chemical probes designed for rapid cellular diffusion enable efficient and sustained target engagement, providing a clearer view of cancer cell signaling networks.